APA (7th ed.) Citation

Meng Zhang, Mei Wang, Zhiming Jiang, Ziyi Fu, Jingjing Ma, & Sheng Gao. (2023). Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. Hindawi-Wiley.

Chicago Style (17th ed.) Citation

Meng Zhang, Mei Wang, Zhiming Jiang, Ziyi Fu, Jingjing Ma, and Sheng Gao. Candidate Oligo Therapeutic Target, MiR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. Hindawi-Wiley, 2023.

MLA (9th ed.) Citation

Meng Zhang, et al. Candidate Oligo Therapeutic Target, MiR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. Hindawi-Wiley, 2023.